Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R01-AI036525)
National Institutes of Health (U19-AI109776, U19-AI082655)
DHHS (U19 AI142725)
Received: 10 September 2020
Accepted: 16 March 2021
First Online: 19 April 2021
: Written informed consent was obtained from subjects and all procedures were approved by the University of Maryland, Baltimore Institutional Review Board (IRB) and registered on ExternalRef removed (identifier NCT03970304). The study was conducted in accordance with the principles of the International Conference of Harmonization Good Clinical Practice guidelines.
: Not applicable.
: The authors declared no conflict of interest.